US stock screener
Every US-listed company we cover, ranked by what it reported to the SEC. Figures come from each company’s own filings (P/E and dividend yield combine SEC share counts and TTM results with a daily price snapshot). Click a column to sort, or open a company for its full statements with per-figure provenance.
All sectorsTechnologyFinancialsHealthcareConsumer DiscretionaryConsumer StaplesEnergyIndustrialsMaterialsUtilitiesReal EstateCommunication Services
558 companies in Healthcare · page 3 of 6
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | Healthcare | $5.16B | $490.7M | 110.5% | -5.2% | -22.2% | — | — |
| NATURES SUNSHINE PRODUCTS INC (NATR) | Healthcare | $368.6M | $480.1M | 5.7% | 4.1% | 12.1% | 19.1 | — |
| Ayr Wellness Inc. (AYRWF) | Healthcare | $1.8M | $463.6M | 0.0% | -77.5% | -98.5% | — | — |
| ACCURAY INC (ARAY) | Healthcare | $30.8M | $458.5M | 2.7% | -0.3% | -2.0% | — | — |
| Zai Lab Ltd (ZLAB) | Healthcare | $2.32B | $457.2M | 15.0% | -38.4% | -24.5% | — | — |
| Tarsus Pharmaceuticals, Inc. (TARS) | Healthcare | $2.45B | $451.4M | 146.7% | -14.7% | -19.3% | — | — |
| ARTIVION, INC. (AORT) | Healthcare | $1.22B | $441.3M | 13.6% | 2.2% | 2.2% | 104 | — |
| GeneDx Holdings Corp. (WGS) | Healthcare | $1.80B | $427.5M | 40.0% | -4.9% | -6.8% | — | — |
| MIMEDX GROUP, INC. (MDXG) | Healthcare | $644.9M | $418.6M | 20.0% | 11.6% | 18.9% | 21.6 | — |
| Innoviva, Inc. (INVA) | Healthcare | $1.57B | $411.3M | 14.7% | 65.9% | 23.1% | 3.5 | — |
| ARDELYX, INC. (ARDX) | Healthcare | $1.28B | $407.3M | 22.1% | -15.1% | -36.9% | — | — |
| Esperion Therapeutics, Inc. (ESPR) | Healthcare | $819.5M | $403.1M | 21.3% | -5.6% | — | — | — |
| Immunocore Holdings plc (IMCR) | Healthcare | $1.73B | $400.0M | 29.0% | -8.9% | -9.3% | — | — |
| Krystal Biotech, Inc. (KRYS) | Healthcare | $10.00B | $389.1M | 33.9% | 52.6% | 16.8% | 45.4 | — |
| SINOVAC BIOTECH LTD (SVA) | Healthcare | — | $386.0M | 6.8% | -51.5% | -3.1% | — | — |
| SONIDA SENIOR LIVING, INC. (SNDA) | Healthcare | $1.92B | $381.1M | 25.2% | -18.6% | — | — | — |
| CareDx, Inc. (CDNA) | Healthcare | $2.05B | $379.8M | 13.8% | -5.6% | -7.0% | — | — |
| Twist Bioscience Corp (TWST) | Healthcare | $5.45B | $376.6M | 20.3% | -20.6% | -16.4% | — | — |
| Arcutis Biotherapeutics, Inc. (ARQT) | Healthcare | $3.56B | $372.1M | 123.4% | -4.3% | -8.5% | — | — |
| InMode Ltd. (INMD) | Healthcare | $882.9M | $370.5M | -6.2% | 25.3% | 13.7% | — | — |
| MANNKIND CORP (MNKD) | Healthcare | $1.23B | $349.0M | 22.2% | 1.7% | — | — | — |
| CASTLE BIOSCIENCES INC (CSTL) | Healthcare | $724.7M | $344.2M | 3.7% | -7.0% | -5.1% | — | — |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | Healthcare | $640.4M | $329.5M | 12.5% | 5.8% | 8.7% | 32.3 | — |
| Fulgent Genetics, Inc. (FLGT) | Healthcare | $556.9M | $322.7M | 13.8% | -18.8% | -5.5% | — | — |
| DocGo Inc. (DCGO) | Healthcare | $64.3M | $322.2M | -47.7% | -56.6% | -144.9% | — | — |
| ANGIODYNAMICS INC (ANGO) | Healthcare | $558.4M | $320.2M | 9.5% | -11.5% | -21.5% | — | — |
| CorMedix Inc. (CRMD) | Healthcare | $610.4M | $311.7M | 617.0% | 52.3% | 40.2% | — | — |
| PROCEPT BioRobotics Corp (PRCT) | Healthcare | $1.09B | $308.1M | 37.2% | -31.0% | -26.1% | — | — |
| BillionToOne, Inc. (BLLN) | Healthcare | $5.99B | $305.1M | 100.0% | 2.4% | 1.6% | — | — |
| SkinHealth Systems Inc. (SKIN) | Healthcare | $102.2M | $300.8M | -10.0% | -3.2% | -15.6% | — | — |
| Evolus, Inc. (EOLS) | Healthcare | $365.2M | $297.2M | 11.6% | -17.4% | — | — | — |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | Healthcare | $633.8M | $296.2M | -15.7% | 8.1% | — | 6.4 | — |
| Inogen Inc (INGN) | Healthcare | $173.3M | $295.3M | 5.9% | -7.7% | -11.8% | — | — |
| RIGEL PHARMACEUTICALS INC (RIGL) | Healthcare | $734.0M | $294.3M | 64.1% | — | 93.8% | 2.1 | — |
| Xeris Biopharma Holdings, Inc. (XERS) | Healthcare | $1.48B | $291.8M | 43.7% | 0.2% | 4.0% | 123 | — |
| Aurinia Pharmaceuticals Inc. (AUPH) | Healthcare | $2.05B | $283.1M | 20.4% | — | 49.4% | 7.4 | — |
| Adaptive Biotechnologies Corp (ADPT) | Healthcare | $3.67B | $277.0M | 54.8% | -21.5% | -26.4% | — | — |
| Vericel Corp (VCEL) | Healthcare | $2.36B | $276.3M | 16.5% | 6.0% | 4.7% | 110 | — |
| HARROW, INC. (HROW) | Healthcare | $1.66B | $272.3M | 36.4% | -1.9% | -9.9% | — | — |
| VIEMED HEALTHCARE, INC. (VMD) | Healthcare | $457.0M | $270.3M | 20.5% | 5.5% | 10.4% | 32.2 | — |
| Vireo Growth Inc. (VREOF) | Healthcare | $480.4M | $268.8M | 170.4% | -25.3% | -22.2% | — | — |
| LIGAND PHARMACEUTICALS INC (LGND) | Healthcare | $6.12B | $268.1M | 60.4% | 46.4% | 12.2% | 41.1 | — |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Healthcare | $2.24B | $263.5M | 60.6% | — | -56.0% | — | — |
| Jushi Holdings Inc. (JUSHF) | Healthcare | $88.5M | $262.9M | 2.1% | -26.1% | — | — | — |
| ARVINAS, INC. (ARVN) | Healthcare | $516.8M | $262.6M | -0.3% | -30.8% | -18.6% | — | — |
| Omada Health, Inc. (OMDA) | Healthcare | $1.37B | $260.2M | 53.2% | -4.9% | -5.6% | — | — |
| Schrodinger, Inc. (SDGR) | Healthcare | $1.13B | $255.9M | 23.3% | -40.4% | -28.4% | — | — |
| LEMAITRE VASCULAR INC (LMAT) | Healthcare | $2.30B | $249.6M | 13.5% | 23.1% | 14.7% | 37.1 | 0.8% |
| Arcus Biosciences, Inc. (RCUS) | Healthcare | $3.71B | $247.0M | -4.3% | — | -55.9% | — | — |
| Keros Therapeutics, Inc. (KROS) | Healthcare | $209.2M | $243.9M | 6769.4% | 35.7% | 28.7% | — | — |
| STAAR SURGICAL CO (STAA) | Healthcare | $1.19B | $239.4M | -23.7% | -33.6% | -23.4% | — | — |
| Vaxart, Inc. (VXRT) | Healthcare | $121.0M | $237.3M | 726.7% | 6.9% | 18.6% | — | — |
| ORTHOPEDIATRICS CORP (KIDS) | Healthcare | $500.6M | $236.3M | 15.4% | -16.8% | -11.4% | — | — |
| Akebia Therapeutics, Inc. (AKBA) | Healthcare | $359.5M | $236.2M | 47.5% | -2.3% | -16.4% | — | — |
| ANAPTYSBIO, INC (ANAB) | Healthcare | $1.72B | $234.6M | 157.0% | -5.6% | -35.6% | — | — |
| CERUS CORP (CERS) | Healthcare | $627.2M | $233.8M | 16.1% | -6.7% | -24.1% | — | — |
| Talkspace, Inc. (TALK) | Healthcare | $872.7M | $228.9M | 22.0% | 3.4% | 6.7% | — | — |
| Lifevantage Corp (LFVN) | Healthcare | $80.1M | $228.5M | 14.2% | 4.3% | 28.3% | 14.1 | 2.8% |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | Healthcare | $436.7M | $228.4M | -0.9% | 13.6% | 23.9% | 17.9 | — |
| Axogen, Inc. (AXGN) | Healthcare | $2.14B | $225.2M | 20.2% | -7.0% | -12.2% | — | — |
| IDEAYA Biosciences, Inc. (IDYA) | Healthcare | $3.37B | $218.7M | 3024.4% | -52.0% | -11.1% | — | — |
| Vanda Pharmaceuticals Inc. (VNDA) | Healthcare | $322.3M | $216.1M | 8.7% | — | -67.4% | — | — |
| AMARIN CORP PLC\UK (AMRN) | Healthcare | $292.3M | $213.6M | -6.5% | -18.2% | -8.4% | — | — |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | Healthcare | $262.7M | $212.7M | 1.6% | -27.7% | -67.6% | — | — |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | Healthcare | $2.76B | $211.1M | 27.1% | -24.2% | -216.9% | — | — |
| Cytek Biosciences, Inc. (CTKB) | Healthcare | $590.2M | $201.5M | 0.5% | -33.0% | -19.5% | — | — |
| SI-BONE, Inc. (SIBN) | Healthcare | $730.4M | $200.9M | 20.2% | -9.4% | -10.6% | — | — |
| Strata Critical Medical, Inc. (SRTA) | Healthcare | $440.4M | $197.1M | 34.3% | 21.0% | 14.8% | 9.1 | — |
| LifeMD, Inc. (LFMD) | Healthcare | $187.6M | $194.1M | 25.3% | 7.4% | 62.0% | — | — |
| LAKELAND INDUSTRIES INC (LAKE) | Healthcare | $111.0M | $192.6M | 15.2% | -13.1% | -19.6% | — | — |
| biote Corp. (BTMD) | Healthcare | $89.6M | $192.2M | -2.5% | 14.1% | — | 5.7 | — |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | Healthcare | $7.04B | $189.8M | 45.8% | — | — | — | — |
| MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Healthcare | $2.58B | $185.7M | -28.3% | -70.4% | -35.1% | — | — |
| Stoke Therapeutics, Inc. (STOK) | Healthcare | $1.85B | $184.4M | 404.5% | -3.7% | -2.0% | — | — |
| Glass House Brands Inc. (GLAS) | Healthcare | $944.4M | $182.0M | -9.4% | -16.3% | — | — | — |
| Adaptimmune Therapeutics PLC (ADAPY) | Healthcare | $8.0M | $178.0M | 195.3% | -39.8% | -597.6% | — | — |
| Cryoport, Inc. (CYRX) | Healthcare | $818.5M | $176.2M | 12.4% | 44.4% | 15.6% | 12.1 | — |
| Heartflow, Inc. (HTFL) | Healthcare | $2.09B | $176.0M | 39.9% | -66.3% | -38.8% | — | — |
| Phathom Pharmaceuticals, Inc. (PHAT) | Healthcare | $933.1M | $175.1M | 216.9% | — | — | — | — |
| SBC Medical Group Holdings Inc (SBC) | Healthcare | $300.6M | $173.6M | -15.5% | 29.4% | 19.4% | 7.5 | — |
| Syndax Pharmaceuticals Inc (SNDX) | Healthcare | $1.88B | $172.4M | 627.8% | — | -441.6% | — | — |
| REGENXBIO Inc. (RGNX) | Healthcare | $656.2M | $170.4M | 104.5% | — | -188.7% | — | — |
| Ginkgo Bioworks Holdings, Inc. (DNA) | Healthcare | $493.2M | $170.2M | -25.1% | — | -61.5% | — | — |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Healthcare | $428.6M | $160.0M | 3.9% | — | -10214.5% | — | — |
| MARIMED INC. (MRMD) | Healthcare | $26.0M | $159.8M | 1.3% | -9.1% | — | — | — |
| Liquidia Corp (LQDA) | Healthcare | $7.74B | $158.3M | 1031.2% | -43.5% | -154.0% | 544 | — |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Healthcare | $88.5M | $154.9M | 7.4% | -13.0% | -140.9% | — | — |
| Airsculpt Technologies, Inc. (AIRS) | Healthcare | $342.9M | $151.8M | -15.8% | -7.7% | -13.3% | — | — |
| MACROGENICS INC (MGNX) | Healthcare | $273.3M | $149.5M | -0.3% | -49.9% | -134.2% | — | — |
| Neuronetics, Inc. (STIM) | Healthcare | $130.8M | $149.2M | 99.2% | -26.1% | -148.6% | — | — |
| ELITE PHARMACEUTICALS INC /NV/ (ELTP) | Healthcare | $398.5M | $148.9M | 77.1% | 30.1% | 45.4% | — | — |
| GRAIL, Inc. (GRAL) | Healthcare | $3.03B | $147.2M | 17.2% | — | -15.8% | — | — |
| Cronos Group Inc. (CRON) | Healthcare | $1.05B | $146.6M | 24.6% | -6.4% | -0.8% | 280 | — |
| Karyopharm Therapeutics Inc. (KPTI) | Healthcare | $162.7M | $146.1M | 0.6% | — | — | — | — |
| InfuSystem Holdings, Inc (INFU) | Healthcare | $179.6M | $143.4M | 6.4% | 4.6% | 11.6% | 24.1 | — |
| Beam Therapeutics Inc. (BEAM) | Healthcare | $2.83B | $139.7M | 120.0% | -57.2% | -6.5% | — | — |
| Quanterix Corp (QTRX) | Healthcare | $184.7M | $138.9M | 1.1% | -77.1% | -36.2% | — | — |
| NRC HEALTH (NRC) | Healthcare | $486.6M | $137.4M | -4.0% | 8.4% | 82.9% | — | 2.4% |
| RxSight, Inc. (RXST) | Healthcare | $222.3M | $134.5M | -3.9% | -29.0% | -14.1% | — | — |
| Xtant Medical Holdings, Inc. (XTNT) | Healthcare | $60.3M | $133.9M | 14.2% | 3.7% | 9.8% | 43.0 | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR (public domain), as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.